Genetic and clinical risk factors associated with phenytoin‐induced cutaneous adverse drug reactions in Thai population-Reference-Cited by-同舟云学术

Genetic and clinical risk factors associated with phenytoin‐induced cutaneous adverse drug reactions in Thai population

Published:2020-03-05 Issue:5 Volume:29 Page:565-574
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Sukasem Chonlaphat¹²,Sririttha Suthida³^ORCID,Tempark Therdpong⁴,Klaewsongkram Jettanong⁵⁶,Rerkpattanapipat Ticha⁶⁷,Puangpetch Apichaya¹²,Boongird Apisit⁸,Chulavatnatol Suvatna³

Affiliation:

1. Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine, Ramathibodi HospitalMahidol University Bangkok Thailand

2. Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC)Ramathibodi Hospital Bangkok Thailand

3. Clinical Pharmacy Division, Department of Pharmacy, Faculty of PharmacyMahidol University Bangkok Thailand

4. Division of Dermatology, Department of Pediatrics, Faculty of MedicineChulalongkorn University Bangkok Thailand

5. Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine, The Skin and Allergy Research UnitChulalongkorn University Bangkok Thailand

6. The Thai Severe Cutaneous Adverse Drug Reaction (THAI‐SCAR) Research GroupChulalongkorn University Bangkok Thailand

7. Division of Allergy Immunology and Rheumatology, Department of Medicine, Faculty of Medicine, Ramathibodi HospitalMahidol University Bangkok Thailand

8. Division of Neurology, Department of Medicine, Faculty of Medicine, Ramathibodi HospitalMahidol University Bangkok Thailand

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.4979

Reference42 articles.

1. Adverse cutaneous drug eruptions: current understanding

2. Adverse drug reactions and organ damage: The skin

3. Exanthematous Drug Eruptions

4. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

5. Toxic epidermal necrolysis and Stevens-Johnson syndrome

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the genetic link: an umbrella review on HLA-B*15:02 and antiepileptic drug-induced Stevens–Johnson syndrome/toxic epidermal necrolysis;Pharmacogenetics and Genomics;2024-03-22

2. Evaluation of severe adverse cutaneous drug reactions in patients admitted to tertiary care center: A cross‐sectional study;Health Science Reports;2024-03

3. Ocular Manifestations and Outcomes in Children With Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Comparison With Adult Patients;American Journal of Ophthalmology;2023-12

4. Why Pharmacovigilance of Non-steroidal Anti-inflammatory Drugs is Important in India?;Endocrine, Metabolic & Immune Disorders - Drug Targets;2023-10-04

5. Unravelling the Genetic Link: An Umbrella Review on HLA-B∗15:02 and Anti-Epileptic Drug-induced Stevens–Johnson Syndrome / Toxic Epidermal Necrolysis;2023-09-19